Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

VANCOMYCIN HYDROCHLORIDE

VANCOMYCIN HYDROCHLORIDE

Standard Dose
EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued
Summary

Approval overview VANCOMYCIN HYDROCHLORIDE is listed in Drugs@FDA under application 209481 (NDA).

Review priority: N/A Marketing status: Discontinued Active ingredient VANCOMYCIN HYDROCHLORIDE Form and strength POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MYLAN LABS LTD Submission history Latest submission status date: 2024-06-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview VANCOMYCIN HYDROCHLORIDE is listed in Drugs@FDA under application 209481 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient VANCOMYCIN HYDROCHLORIDE Form and strength POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MYLAN LABS LTD Submission history Latest submission status date: 2024-06-26 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.